|
Market Closed -
CBOE
11:30:00 2026-09-21 EDT
|
After hours 16:00:01 | |||
| 131.66 EUR | +2.36% |
|
131.35 | -0.24% |
| 09-18 | Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2% | MT |
| 09-16 | Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,028B | |||||
| 651B | - | ||||
| 466B | |||||
| 346B | |||||
| 266B |
Select your edition
All financial news and data tailored to specific country editions
